CoChat

Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials

Jia, Xiaoming, Kohli, Payal, Virani, Salim S. · 2019 · Current Atherosclerosis Reports

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Purpose of review Omega-3 fatty acids (ω-3 FA) are among the most well-recognized health supplements but their cardiovascular benefits have long been controversial owing to inconsistent results from previous cardiovascular outcomes trials (CVOT). In this article, we provide a short review of existing literature followed by recent randomized clinical trial data, with a discussion of the potential clinical implications of these new findings.Recent findings Data from the randomized, controlled trial REDUCE-IT, when viewed within the context of other recently published trials ASCEND and VITAL, add to a growing body of evidence on the use of ω-3 FA therapies in the treatment of atherosclerotic cardiovascular disease (ASCVD). Given the different formulations, dosages, and patient populations studied, CVOTs of ω-3 FA have provided valuable insight into the use of these agents in cardioprotection. Current data suggest that higher dosages of pure eicosapentaenoic acid ω-3 FA formulations provide additional benefit in reduction of ASCVD events.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11883-019-0763-0

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 44

Metadata

Authors
Jia, X., Kohli, P., & Virani, S. S.
Affiliations
  • Baylor College of Medicine (US)
  • Michael E. DeBakey VA Medical Center (US)
Corresponding author
Virani, Salim S.
Venue
Current Atherosclerosis Reports
Published
2019-01
Volume
21
Issue
1
Pages
1-1
ISSN
  • 1523-3804 (ISSN-L)
  • 1534-6242
OpenAlex
W2909069259
Cited by
39
References
45
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 10 · 2020: 7 · 2019: 10
FWCI
1.02
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Atherosclerosis Reports (publishedVersion)
  • PubMed (publishedVersion)
  • eCommons - AKU (Aga Khan University) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
omega-3 fatty acids, cardiovascular outcomes, eicosapentaenoic acid, atherosclerotic cardiovascular disease, REDUCE-IT trial, ASCEND trial, VITAL trial, cardioprotection, dosage
MeSH terms
Cardiotonic Agents, Cardiovascular Diseases, Diabetes Mellitus, Docosahexaenoic Acids, Heart Failure, Humans, Myocardial Infarction, Eicosapentaenoic Acid, Hypertriglyceridemia, Randomized Controlled Trials as Topic, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials. https://app.cochat.ai/papers/10.1007/s11883-019-0763-0
The paper
Jia, X., Kohli, P., & Virani, S. S. (2019). Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials. Current Atherosclerosis Reports. https://doi.org/10.1007/s11883-019-0763-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.